Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Debt Ratio (2021 - 2026)

Indivior Pharmaceuticals has reported Debt Ratio over the past 6 years, most recently at 0.41 for Q1 2026.

  • For Q1 2026, Debt Ratio rose 69.69% year-over-year to 0.41; the TTM value through Mar 2026 reached 0.41, up 69.69%, while the annual FY2025 figure was 0.27, 4.97% up from the prior year.
  • Debt Ratio for Q1 2026 was 0.41 at Indivior Pharmaceuticals, up from 0.27 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.41 in Q1 2026 and troughed at 0.14 in Q4 2022.
  • A 5-year average of 0.24 and a median of 0.23 in 2025 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: increased 0.63% in 2023 and later soared 85.35% in 2024.
  • Year by year, Debt Ratio stood at 0.14 in 2022, then increased by 0.63% to 0.14 in 2023, then skyrocketed by 85.35% to 0.25 in 2024, then rose by 4.97% to 0.27 in 2025, then skyrocketed by 52.86% to 0.41 in 2026.
  • Business Quant data shows Debt Ratio for INDV at 0.41 in Q1 2026, 0.27 in Q4 2025, and 0.23 in Q3 2025.